Stimulant Oxytocin Study (SOS)
6-week Trial of Oxytocin for Co-occurring Cocaine and Opioid Use Disorders
Sponsor: VA Office of Research and Development
Listed as NCT03016598, this PHASE2 trial focuses on Stimulant Use & Co-occuring Opioid Use Disorders and remains completed. Sponsored by VA Office of Research and Development, it has been updated 14 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Sep 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Sep 2021 [monthly]
Completed PHASE2
-
Mar 2020 — Jan 2021 [monthly]
Completed PHASE2
Status: Recruiting → Completed
▶ Show 9 earlier versions
-
Feb 2020 — Mar 2020 [monthly]
Recruiting PHASE2
-
Dec 2019 — Feb 2020 [monthly]
Recruiting PHASE2
-
Jul 2019 — Dec 2019 [monthly]
Recruiting PHASE2
-
Feb 2019 — Jul 2019 [monthly]
Recruiting PHASE2
-
Aug 2018 — Feb 2019 [monthly]
Recruiting PHASE2
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE2
-
Mar 2018 — Jun 2018 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Sep 2017 — Mar 2018 [monthly]
Not Yet Recruiting PHASE2
-
Feb 2017 — Sep 2017 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- VA Office of Research and Development
For direct contact, visit the study record on ClinicalTrials.gov .